These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21944272)

  • 1. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.
    Briana DD; Gourgiotis D; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    Metabolism; 2012 Mar; 61(3):335-40. PubMed ID: 21944272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
    Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
    Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of novel adipocytokines with bone biomarkers in intra uterine growth-restricted fetuses/neonates at term.
    Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):984-8. PubMed ID: 24106768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.
    Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A
    Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
    Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
    Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
    Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal collagen turnover markers in intrauterine growth restriction.
    Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.
    Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C in pregnancies with normal and restricted fetal growth.
    Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D
    Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.
    Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies.
    Kontara L; Briana DD; Baka S; Boutsikou M; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A
    Fetal Diagn Ther; 2008; 24(3):220-4. PubMed ID: 18753761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
    Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
    Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A
    Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine growth restriction and circulating neurotrophin levels at term.
    Malamitsi-Puchner A; Nikolaou KE; Economou E; Boutsikou M; Boutsikou T; Kyriakakou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2007 Jul; 83(7):465-9. PubMed ID: 17071024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating apelin concentrations in mother/infant pairs at term.
    Malamitsi-Puchner A; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Briana DD
    Acta Paediatr; 2007 Dec; 96(12):1751-4. PubMed ID: 18001333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life.
    El Shemi MS; Mohamed MH; AbdelRahman AO; Abdel Al H; Ramadan NM
    J Neonatal Perinatal Med; 2016; 9(1):73-82. PubMed ID: 27002258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
    Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
    Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction.
    Briana DD; Boutsikou M; Baka S; Papadopoulos G; Gourgiotis D; Puchner KP; Hassiakos D; Malamitsi-Puchner A
    Mediators Inflamm; 2007; 2007():65032. PubMed ID: 18274642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma copeptin may not be a sensitive marker of perinatal stress in healthy full-term growth-restricted fetuses.
    Briana DD; Boutsikou M; Boutsikou T; Dodopoulos T; Gourgiotis D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):705-709. PubMed ID: 27125294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction.
    Malamitsi-Puchner A; Boutsikou T; Economou E; Makrakis E; Iliodromiti Z; Kouskouni E; Hassiakos D
    J Soc Gynecol Investig; 2005 Apr; 12(3):195-7. PubMed ID: 15784505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.